Biomolecular Sciences Research Centre
Our Research
Accessibility of Science
Understanding how people engage with bioscience and chemistry, and developing more inclusive approaches to science education and public engagement.
Find out moreBioanalytical science
Developing and applying advanced mass spectrometry and molecular imaging approaches across biological, pharmaceutical and forensic research.
Find out moreCancer research
Investigating cancer mechanisms, therapeutic response and translational interventions, alongside bioinformatics and data-driven approaches.
Find out moreChemistry
Developing chemical, analytical and materials-based approaches for biomedical, environmental and industrial challenges.
Find out moreHealth disease and molecular biosciences
Understanding disease and human health through advanced cell models, molecular signalling, immunology, environmental physiology and related approaches.
Find out moreMicrobiology and biotechnology
Using microbial systems to address challenges including antimicrobial resistance, infection, environmental contamination and sustainable biotechnology.
Find out moreResearch Impact
Citizen scientists
The current citizen-science project has good evidence: over two years, the public supplied more than 4,500 photographs to help monitor nature-based flood interventions, and the resulting research has informed how partners such as the Environment Agency and Sheffield & Rotherham Wildlife Trust manage and extend the approach.
Read more
Molecular fingerprinting
BMRC-led research in molecular fingerprinting has contributed to an AI-powered system using MALDI mass spectrometry imaging to recover and analyse molecular fingermark images. The technology has been trialled by West Yorkshire Police following collaboration involving Sheffield Hallam, the University of Bradford, Molecular Discovery, Waters Corporation and regional forensic services.
Read more
Healthcare award
A longstanding Sheffield Hallam partnership with Paxman has used cell-biology research to inform technologies aimed at reducing chemotherapy-induced hair loss and other treatment side effects; the partnership was shortlisted for a Medilink North of England healthcare award in 2025.
Read more